Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials期刊界 All Journals 搜尽天下杂志传播学术成果专业期刊搜索期刊信息化学术搜索

按检索

Efficacy and acceptability of selective serotonin reuptake inhibitors for the treatment of depression in Parkinson's disease: a systematic review and meta-analysis of randomized controlled trials

Authors:	Petros Skapinakis Eleni Bakola Georgia Salanti Glyn Lewis Athanasios P Kyritsis Venetsanos Mavreas

Institution:	(1) Department of Psychiatry, University of Ioannina School of Medicine, Ioannina, 45110, Greece;(2) Academic Unit of Psychiatry, University of Bristol, Cotham House, Cotham Hill, Bristol, BS66JL, UK;(3) Department of Hygiene and Epidemiology, University of Ioannina School of Medicine, Ioannina, 45110, Greece;(4) Department of Neurology, University of Ioannina School of Medicine, Ioannina, 45110, Greece

Abstract:	Background Selective serotonin reuptake inhibitors (SSRIs) are the most commonly prescribed antidepressants for the treatment of depression in patients with Parkinson's Disease (PD) but data on their efficacy are controversial.

Keywords:
本文献已被 SpringerLink 等数据库收录！